Literature DB >> 9248978

Strategies to minimize the development of antibiotic resistance.

F Baquero1, M C Negri.   

Abstract

The choice of appropriate antimicrobial agents should take into consideration not only the interests of the individual patient, but also the ecological impact of different drugs and their delivery schedules. Selection of antibiotic-resistant organisms is a key aspect to remember. Bacterial populations harboring determinants of antibiotic resistance will be selected for by a range of antibiotic concentrations which are able to suppress or slow the growth of susceptible populations. These concentrations (selective concentrations) will be achieved within the human body in a series of compartments (selective compartments), where the potential selective power will be roughly proportional to the time of exposure of the bacteria to the drug (selective period). The duration of the expected exposure of bacterial populations to these concentrations of the drugs and the number of challenges they experience are probably the most important factors in predicting the potential selective activity of an antibiotic regimen. Such a risk analysis procedure may be used to propose guidelines for minimizing the development of antibiotic resistance.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9248978

Source DB:  PubMed          Journal:  J Chemother        ISSN: 1120-009X            Impact factor:   1.714


  16 in total

Review 1.  Dosing regimen matters: the importance of early intervention and rapid attainment of the pharmacokinetic/pharmacodynamic target.

Authors:  Marilyn N Martinez; Mark G Papich; George L Drusano
Journal:  Antimicrob Agents Chemother       Date:  2012-02-27       Impact factor: 5.191

2.  Mutant prevention concentrations of fluoroquinolones for Enterobacteriaceae expressing the plasmid-carried quinolone resistance determinant qnrA1.

Authors:  J M Rodríguez-Martínez; C Velasco; I García; M E Cano; L Martínez-Martínez; A Pascual
Journal:  Antimicrob Agents Chemother       Date:  2007-04-02       Impact factor: 5.191

3.  A case of methicillin-resistant Staphylococcus aureus infection following bile duct stenting.

Authors:  Markus-K Diener; Alexis Ulrich; Theresia Weber; Moritz N Wente; Markus W Büchler; Helmut Friess
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

4.  Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae.

Authors:  Kelli Metzler; Karl Drlica; Joseph M Blondeau
Journal:  J Antimicrob Chemother       Date:  2012-11-20       Impact factor: 5.790

5.  Emergence of Resistance in Klebsiella aerogenes to Piperacillin-Tazobactam and Ceftriaxone.

Authors:  Marco M Custodio; Daniel Sanchez; Beverly Anderson; Keenan L Ryan; Carla Walraven; Renee-Claude Mercier
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

6.  In vitro selection of resistance to four beta-lactams and azithromycin in Streptococcus pneumoniae.

Authors:  G A Pankuch; S A Jueneman; T A Davies; M R Jacobs; P C Appelbaum
Journal:  Antimicrob Agents Chemother       Date:  1998-11       Impact factor: 5.191

Review 7.  Drug interactions and the evolution of antibiotic resistance.

Authors:  Pamela J Yeh; Matthew J Hegreness; Aviva Presser Aiden; Roy Kishony
Journal:  Nat Rev Microbiol       Date:  2009-06       Impact factor: 60.633

8.  Pharmacodynamic Evaluation of the Potential Clinical Utility of Fosfomycin and Meropenem in Combination Therapy against KPC-2-Producing Klebsiella pneumoniae.

Authors:  James Albiero; Sherwin K B Sy; Josmar Mazucheli; Silvana Martins Caparroz-Assef; Bruno Buranello Costa; Janio Leal Borges Alves; Ana Cristina Gales; Maria Cristina Bronharo Tognim
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

9.  In vitro activities of oral beta-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance.

Authors:  C E Thorburn; S J Knott; D I Edwards
Journal:  Antimicrob Agents Chemother       Date:  1998-08       Impact factor: 5.191

10.  Implications of amino acid substitutions in GyrA at position 83 in terms of oxolinic acid resistance in field isolates of Burkholderia glumae, a causal agent of bacterial seedling rot and grain rot of rice.

Authors:  Yukiko Maeda; Akinori Kiba; Kouhei Ohnishi; Yasufumi Hikichi
Journal:  Appl Environ Microbiol       Date:  2004-09       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.